Igor Richter
Kolin, ST, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Cabozantinib in the First-Line Treatment of Patients With Metastatic Renal Cell Carcinoma, Real-World Data From the Czech Republic and Poland: ICARO-RC Project.
Journal: Clinical genitourinary cancer
Published: March 06, 2025
Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model.
Journal: British journal of clinical pharmacology
Published: February 28, 2024
Enzalutamide and abiraterone in the treatment of patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy.
Journal: Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti
Published: January 09, 2024
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.
Journal: Targeted oncology
Published: October 20, 2023
Association of the combined parameters including the frequency of primary cilia, PD-L1, Smoothened protein, membranous β-catenin and cytoplasmic β-catenin expression with the outcome of patients with clear cell renal cell carcinoma.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Published: October 04, 2023
Favorable prognostic significance of membranous β-catenin expression and negative prognostic significance of cytoplasmic β-catenin expression in pancreatic cancer.
Journal: Neoplasma
Published: July 21, 2023
Abiraterone and enzalutamide in the first line therapy of metastatic castration resistant prostate cancer.
Journal: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
Published: June 05, 2023
Sarcopenia in Metastatic Renal Cell Carcinoma Patients Treated with Cabozantinib.
Journal: Targeted oncology
Published: August 05, 2020
Patients with metastatic renal cell carcinoma treated with cabozantinib in the Czech Republic: analysis of four cancer centers.
Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Published: July 29, 2020
Care of patients with non-small-cell lung cancer stage III - the Central European real-world experience.
Journal: Radiology and oncology
Published: January 09, 2020
Last Updated: 09/26/2026